Skip to main content
NCBI home page
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 2003;101:53–57.

Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments.

Devron H Char 1, Riley Bove 1, Theodore L Phillips 1
PMCID: PMC1358974  PMID: 14971563

Abstract

PURPOSE: To assess whether laser-induced hyperthermia in conjunction with proton irradiation of choroidal melanoma may more rapidly decrease exudative retinal detachments. DESIGN: Case-control study. METHODS: This was a single-center prospective phase 1 study of choroidal melanoma patients with exudative retinal detachments. These tumors did not overhang the optic disc, involve the fovea, or have greater than 40% involvement of the ciliary body. Patients were treated with laser-induced hyperthermia and proton radiation; results were compared with those of similar patients treated at the same institution with only proton radiation. Patients were followed up in an identical manner for loss of subretinal fluid, visual acuity change, and visual field alterations. RESULTS: All 11 patients treated with combined laser and proton therapy had resorption of subretinal fluid with a mean duration of retinal detachment of 193 days, compared with 263 days in the group treated with only proton therapy (P<.04). At 1 year, visual acuity was similar in both groups. CONCLUSIONS: Combined laser-induced hyperthermia and proton radiation may dissipate exudative detachments more rapidly than radiation alone.

Full Text

The Full Text of this article is available as a PDF (162.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butler P., Char D. H., Zarbin M., Kroll S. Natural history of indeterminate pigmented choroidal tumors. Ophthalmology. 1994 Apr;101(4):710–717. doi: 10.1016/s0161-6420(94)31274-7. [DOI] [PubMed] [Google Scholar]
  2. Char D. H., Kroll S. M., Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol. 1998 Jan;125(1):81–89. doi: 10.1016/s0002-9394(99)80238-4. [DOI] [PubMed] [Google Scholar]
  3. Char D. H., Lonn L. I., Margolis L. W. Complications of cobalt plaque therapy of choroidal malanomas. Am J Ophthalmol. 1977 Oct;84(4):536–541. doi: 10.1016/0002-9394(77)90448-2. [DOI] [PubMed] [Google Scholar]
  4. Char D. H., Quivey J. M., Castro J. R., Kroll S., Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology. 1993 Oct;100(10):1547–1554. doi: 10.1016/s0161-6420(93)31446-6. [DOI] [PubMed] [Google Scholar]
  5. Desjardins L., Levy C., d'Hermies F., Frau E., Schlienger P., Habrand J. L., Mammar H., Schwartz L., Mazal A., Delacroix S. Résultats préliminaires de la protonthérapie du mélanome de la choroïde au centre de protonthérapie d'Orsay (CPO): les 464 premiers cas. Cancer Radiother. 1997;1(3):222–226. doi: 10.1016/s1278-3218(97)89768-5. [DOI] [PubMed] [Google Scholar]
  6. Diaz C. E., Capone A., Jr, Grossniklaus H. E. Clinicopathologic findings in recurrent choroidal melanoma after transpupillary thermotherapy. Ophthalmology. 1998 Aug;105(8):1419–1424. doi: 10.1016/S0161-6420(98)98022-8. [DOI] [PubMed] [Google Scholar]
  7. Egger E., Schalenbourg A., Zografos L., Bercher L., Boehringer T., Chamot L., Goitein G. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):138–147. doi: 10.1016/s0360-3016(01)01560-7. [DOI] [PubMed] [Google Scholar]
  8. Gragoudas E. S. 1996 Jules Gonin Lecture of the Retina Research Foundation. Long-term results after proton irradiation of uveal melanomas. Graefes Arch Clin Exp Ophthalmol. 1997 May;235(5):265–267. doi: 10.1007/BF01739634. [DOI] [PubMed] [Google Scholar]
  9. Harbour J. W., Char D. H., Kroll S., Quivey J. M., Castro J. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology. 1997 Nov;104(11):1785–1793. doi: 10.1016/s0161-6420(97)30025-6. [DOI] [PubMed] [Google Scholar]
  10. Harbour J. William, Ahmad Saad, El-Bash Mohammed. Rate of resolution of exudative retinal detachment after plaque radiotherapy for uveal melanoma. Arch Ophthalmol. 2002 Nov;120(11):1463–1469. doi: 10.1001/archopht.120.11.1463. [DOI] [PubMed] [Google Scholar]
  11. Imamura Masahiro, Sawada Satoshi, Kasahara-Imamura Mika, Harima Keizo, Harada Kazuki. Synergistic cell-killing effect of a combination of hyperthermia and heavy ion beam irradiation: in expectation of a breakthrough in the treatment of refractory cancers (review). Int J Mol Med. 2002 Jan;9(1):11–18. [PubMed] [Google Scholar]
  12. Journée-de Korver J. G., Oosterhuis J. A., de Wolff-Rouendaal D., Kemme H. Histopathological findings in human choroidal melanomas after transpupillary thermotherapy. Br J Ophthalmol. 1997 Mar;81(3):234–239. doi: 10.1136/bjo.81.3.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kivelä T., Eskelin S., Mäkitie T., Summanen P. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2085–2093. [PubMed] [Google Scholar]
  14. Kivelä T., Eskelin S., Mäkitie T., Summanen P. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2085–2093. [PubMed] [Google Scholar]
  15. Kociecki J., Biczysko W., Korver H. G., Keunen J. E., Pecold K. Additional cell damage after transpupillary thermotherapy in choroidal malignant melanoma. Melanoma Res. 2001 Oct;11(5):511–515. doi: 10.1097/00008390-200110000-00011. [DOI] [PubMed] [Google Scholar]
  16. Kurhanewicz J., Char D. H., Stauffer P., Quivey J. M., James T. L. 31P magnetic resonance spectroscopy after combined hyperthermia and radiation. Curr Eye Res. 1994 Feb;13(2):151–156. doi: 10.3109/02713689409042410. [DOI] [PubMed] [Google Scholar]
  17. Robertson D. M., Buettner H., Bennett S. R. Transpupillary thermotherapy as primary treatment for small choroidal melanomas. Trans Am Ophthalmol Soc. 1999;97:407–434. [PMC free article] [PubMed] [Google Scholar]
  18. Seregard S., Landau I. Transpupillary thermotherapy as an adjunct to ruthenium plaque radiotherapy for choroidal melanoma. Acta Ophthalmol Scand. 2001 Feb;79(1):19–22. doi: 10.1034/j.1600-0420.2001.079001019.x. [DOI] [PubMed] [Google Scholar]
  19. Shields C. L., Shields J. A., Kiratli H., De Potter P., Cater J. R. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology. 1995 Sep;102(9):1351–1361. [PubMed] [Google Scholar]
  20. Shields Carol L., Cater Jacqueline, Shields Jerry A., Chao Aning, Krema Hatem, Materin Miguel, Brady Luther W. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients. Arch Ophthalmol. 2002 Jul;120(7):933–940. doi: 10.1001/archopht.120.7.933. [DOI] [PubMed] [Google Scholar]
  21. Shields Carol L., Shields Jerry A., Perez Noel, Singh Arun D., Cater Jacqueline. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology. 2002 Feb;109(2):225–234. doi: 10.1016/s0161-6420(01)00902-2. [DOI] [PubMed] [Google Scholar]
  22. Starzycka M., Romanowska-Dixon B., Słomska J., Szpakowicz U. Przezźreniczna termoterapia w skojarzeniu z brachyterapia 106Ru jako metoda postepowania w czerniaku naczyniówki. Klin Oczna. 2000;102(4):249–252. [PubMed] [Google Scholar]
  23. Stoffelns Bernhard M., Kutzner Joachim, Schöpfer Kilian, Frising Martine. Prospektive nicht randomisierte Analyse der "Sandwich-Therapie" beim malignen Melanom der Aderhaut. Klin Monbl Augenheilkd. 2002 Apr;219(4):211–215. doi: 10.1055/s-2002-30652. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES